Incretin-based Therapies in the Treatment of Metabolic Syndrome: Expanding Roles Beyond Weight Management

Genetic variability in sodium-glucose cotransporter 2 and glucagonlike peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice

• Gašper Tonin
• Katja Goričar
• Tanja Blagus
• Andrej Janez
• Vita Dolzan
• Jasna Klen